MRNA

Moderna Stock Price

103.71
5.15 (5.23%)
Upgrade to Real-Time
Regular Market
103.71
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
5.15 5.23% 103.71 09:50:45
Open Price Low Price High Price Close Price Previous Close
99.20 98.65 103.7875 98.56
Bid Price Ask Price Spread News
103.69 103.75 0.06 - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
27,997 3,041,333 $ 100.52 $ 305,722,701 12,193,445 17.68 - 104.96
Last Trade Time Type Quantity Stock Price Currency
09:50:45 20 $ 103.75 USD

Moderna Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 39.47B 395.71M 304.03M $ 60.21M $ - -1.54 -60.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Moderna News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week93.92104.9688.610395.1716,322,0709.7910.42%
1 Month68.95104.9665.489988.1915,770,30434.7650.41%
3 Months62.84104.9654.2178.0810,486,06240.8765.04%
6 Months66.40104.9646.130172.8716,502,00437.3156.19%
1 Year20.90104.9617.6859.1314,786,64082.81396.22%
3 Years22.00104.9611.5455.388,383,17381.71371.41%
5 Years22.00104.9611.5455.388,383,17381.71371.41%

Moderna Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life. The firm is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases. Its clinical trials include mRNA-1647, mRNA-1893, mRNA-4157, and mRNA-2416 among others.
Your Recent History
NASDAQ
MRNA
Moderna
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201125 15:05:48